Bovie Medical (BVX) Stock Price, News & Analysis

Company Overview

Bovie Medical Corporation was a medical technology company that developed and marketed electrosurgical products for hospitals, physicians and other healthcare providers. Its product portfolio included electrosurgical generators, pencils, electrodes, handpieces and related accessories used for cutting, coagulation and tissue management during surgical procedures.

The company also developed J-Plasma, a technology that combines helium gas with radio-frequency energy to create a focused plasma stream. J-Plasma systems were designed for use in open, laparoscopic and minimally invasive procedures, with applications across several surgical specialties. Bovie Medical marketed products under the Bovie brand and sold through direct and distributor channels in the United States and international markets.

In 2018, Bovie Medical changed its corporate name to Apyx Medical Corporation and began trading under the ticker symbol APYX. The rebranding reflected the company’s increasing focus on its J-Plasma technology, while its electrosurgical products continued to serve as part of its medical device business.

Key Stats

• Today's Range: $6.35 to $6.71
• 50-Day Range: $6.48 to $6.48
• 52-Week Range: $2.28 to $7.70
• Volume: 129,500 shs
• Average Volume: 136,878 shs
• Market Capitalization: $215.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/01/2018
• Today: 9/21/2026

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSEAMERICAN:BVX
• Previous Symbol: AMEX:BVX
• CIK: 719135
• Web: www.boviemedical.com
• Phone: (727) 384-2323
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 33,200,000
• Free Float: N/A
• Market Cap: $215.14 million
• Optionable: Not Optionable
• Beta: N/A